| Q54526061 | 7th Drug hypersensitivity meeting: part two. |
| Q55106781 | A Perspective on the Interplay of Ultraviolet-Radiation, Skin Microbiome and Skin Resident Memory TCRαβ+ Cells. |
| Q53223990 | Activation of Flucloxacillin-Specific CD8+ T-Cells With the Potential to Promote Hepatocyte Cytotoxicity in a Mouse Model. |
| Q46701571 | Anti-inflammatory and immune-regulatory mechanisms prevent contact hypersensitivity to Arnica montana L. |
| Q91477480 | Automatic depletion with Spectra Optia allows a safe 16% reduction of red blood cell pack consumption in exchanged sickle cell anemia patients |
| Q53895280 | CD4+ T cells prevent skin autoimmunity during chronic autologous graft-versus-host-disease. |
| Q46926239 | CD8+ T cells are effector cells of contact dermatitis to common skin allergens in mice. |
| Q89506044 | CD8+ T cells mediate ultraviolet A-induced immunomodulation in a model of extracorporeal photochemotherapy |
| Q46058066 | Characterization of Flucloxacillin-specific CD8+ T-cells in a mouse model. |
| Q38474290 | Contribution of CD4(+ )and CD8(+) T-cells in contact hypersensitivity and allergic contact dermatitis. |
| Q89527829 | Current perspective of the etiopathogenesis of delayed-type, and T-cell-mediated drug-related skin diseases |
| Q80651085 | Depletion of human peripheral blood lymphocytes in CD25+ cells allows for the sensitive in vitro screening of contact allergens |
| Q50134738 | Drug-induced aseptic meningitis: A possible T-cell-mediated hypersensitivity. |
| Q37617470 | Effector and regulatory mechanisms in allergic contact dermatitis. |
| Q41425576 | Encapsulation of hydrophobic allergens into nanoparticles improves the in vitro immunological diagnosis of allergic contact dermatitis. |
| Q38161481 | Human T cell priming assay: depletion of peripheral blood lymphocytes in CD25(+) cells improves the in vitro detection of weak allergen-specific T cells. |
| Q48247956 | IL-1β induces thymic stromal lymphopoietin and an atopic dermatitis-like phenotype in reconstructed healthy human epidermis |
| Q42667819 | Inducible costimulator (ICOS) is a marker for highly suppressive antigen-specific T cells sharing features of TH17/TH1 and regulatory T cells. |
| Q91091626 | Inhibitory checkpoint receptors control CD8+ resident memory T cells to prevent skin allergy |
| Q35913679 | Langerhans cells protect from allergic contact dermatitis in mice by tolerizing CD8(+) T cells and activating Foxp3(+) regulatory T cells. |
| Q90363443 | Long-lasting allergic contact dermatitis to methylisothiazolinone misdiagnosed as atopic dermatitis |
| Q55206202 | P11-05. Induction of CD8+ T cell mediated immune responses through skin and mucosa: identification of immunostimulatory versus tolerogenic dendritic cells. |
| Q84911251 | SLIT prevents the development of eczema in percutaneous allergen-sensitized mice |
| Q38464149 | Skin contact irritation conditions the development and severity of allergic contact dermatitis. |
| Q82588700 | Skin exposure to weak and moderate contact allergens induces IFNgamma production by lymph node cells of CD4+ T-cell-depleted mice |
| Q80178370 | Skin-infiltrating CD8+ T cells initiate atopic dermatitis lesions |
| Q47884985 | State-of-the-art and new options to assess T cell activation by skin sensitizers: Cosmetics Europe Workshop. |
| Q37780711 | T-cell recognition of chemicals, protein allergens and drugs: towards the development of in vitro assays. |
| Q83310841 | The skin allergenic properties of chemicals may depend on contaminants--evidence from studies on coumarin |
| Q28072685 | Topical Ivermectin 10 mg/g and Oral Doxycycline 40 mg Modified-Release: Current Evidence on the Complementary Use of Anti-Inflammatory Rosacea Treatments |
| Q40385739 | Topical ivermectin improves allergic skin inflammation. |
| Q53571005 | UV Radiation Induces the Epidermal Recruitment of Dendritic Cells that Compensate for the Depletion of Langerhans Cells in Human Skin. |
| Q80730761 | Which house-keeping genes for dendritic cell transcriptomic studies? |
| Q82466840 | [Allergic contact dermatitis: how to re-induce tolerance?] |
| Q84419136 | [Epicutaneous testing of patients presenting atopic dermatitis: atopy patch tests] |
| Q83051910 | [Epidemiology and pathophysiology of eczemas] |
| Q82862470 | [Sensitisation versus tolerance in contact eczema] |